TELO

NASDAQ · Equity

Telomir Pharmaceuticals, Inc. Common Stock

US Healthcare Biotechnology

Latest week
29 May 2026
Close
1.300000
Fair value
3.473708
Expectation
Negative 38.36%
Weekly Close Trend Line Fair Value Activity Lines

Chart Summary

Key Points

Week Ending
29 May 2026
Latest Close
1.30
12-Week Change
-1.52%
Trend Signal
Inactive
Expectation
Negative 38.36%
Signal Weeks
0 of 12
Vs Trend Line
Below
Vs Fair Value
Below
Relative Strength
-26.32
Market Dynamics
1.43

Over the latest 12 completed weeks ending 2026-05-29, TELO fell 1.52%, moving from 1.32 to 1.30. The latest weekly close is below the Trend Line and below Fair Value. Trend Signal is inactive on the latest week and was active in 0 of the last 12 weeks. Relative Strength is -26.32 and has improved across the 12-week window. Market Dynamics is 1.43 on the latest week. Expectation is negative at 38.36%.